Plasma cyclic guanosine monophosphate in chronic heart failure: Hemodynamic and neurohormonal correlations and response to nitrate therapy

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Clinical pharmacology and therapy

• Publication date

  1993-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/clpt.1993.201PMID 7903916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitroglycerin tolerance in vitro: effect on cGMP turnover in vascular smooth muscle.

  2009cited by this paper
• Mechanisms of nitrate-induced vasodilatation and tolerance

  2005cited by this paper
• Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation.

  1991cited by this paper
• Clinical aspects of nitrate tolerance.

  1991cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

  1991cited by this paper
• Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism.

  1991cited by this paper
• Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases.

  1991cited by this paper
• Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system.

  1991cited by this paper
• Cell biology of atrial natriuretic peptide.

  1991cited by this paper
• Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention.

  1991cited by this paper
• Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.

  1991cited by this paper
• Pathophysiologic and prognostic considerations in circulatory insufficiency in congestive heart failure: receptor function.

  1989cited by this paper
• Direct regulation of smooth muscle contractile elements by second messengers.

  1989cited by this paper
• [Plasma level of cyclic nucleotides in patients with congestive heart failure and their clinical significance].

  1989cited by this paper
• Cellular mechanisms of nitrate action.

  1989cited by this paper
• Cyclic Guanosine Monophosphate‐Enhanced Sequestration of Ca2+ by Sarcoplasmic Reticulum in Vascular Smooth Muscle

  1988cited by this paper
• Ovine fetal and adult atrial natriuretic factor metabolism.

  1988cited by this paper
• Hepatic cyclic GMP formation is regulated by similar factors that modulate activation of purified hepatic soluble guanylate cyclase.

  1987cited by this paper
• Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.

  1987cited by this paper
• Plasma concentrations of alpha-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease.

  1987cited by this paper
• Cyclic Guanosine Monophosphate Inhibition of Contraction May be Mediated through Inhibition of Phosphatidylinositol Hydrolysis in Rat Aorta

  1986cited by this paper
• The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase

  1985cited by this paper
• Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.

  1985cited by this paper
• Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man.

  1985cited by this paper
• Increased plasma cyclic nucleotide concentrations in congestive heart failure.

  1984cited by this paper
• Effect of native and synthetic atrial natriuretic factor on cyclic GMP.

  1984cited by this paper
• Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.

  1984cited by this paper
• Mechanism of nitrate-induced vasodilation and tolerance.

  1983cited by this paper
• Cardiac output by thermodilution technique. Effect of injectate's volume and temperature on accuracy and reproducibility in the critically Ill patient.

  1983cited by this paper
• Mechanism of Acid‐Activation of Renin: Role of Kallikrein in Renin Activation

  1981cited by this paper
• Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man.

  1981cited by this paper
• Effects of Nitroglycerin Ointment on Plasma Norepinephrine and Cyclic Nucleotides in Congestive Heart Failure

  1981cited by this paper
• Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

  1981cited by this paper
• Adrenergic and cholinergic modulation of extracellular cyclic nucleotides.

  1980cited by this paper
• Purification of soluble guanylate cyclase from rat lung.

  1979cited by this paper
• Plasma cyclic GMP: response to cholinergic agents.

  1978cited by this paper
• Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.

  1977cited by this paper
• Alteration of vein cyclic 3':5' nucleotide concentrations during changes in contractility.

  1974cited by this paper

• Association of natriuretic peptides and receptor activity with cardio-metabolic health at middle age

  2024cites this paper
• Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis

  2022cites this paper
• Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study

  2020cites this paper
• Associations Between the Cyclic Guanosine Monophosphate Pathway and Cardiovascular Risk Factors: MESA

  2019cites this paper
• Nitrates and Left Ventricular Dysfunction

  2007cites this paper
• Neurohumoral Changes in Patients With Left Ventricular Dysfunction Following Acute Myocardial Infarction and the Effect of Nitrate Therapy: A Randomized, Double-Blind, Placebo-Controlled Long-Term Study

  2006cites this paper
• Cyclic GMP transporters.

  2004cites this paper
• Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure.

  2002cites this paper
• Die neurohumorale Regulation bei chronischer Herzinsuffizienz Einfluss des ACE-Hemmers Perindopril und Korrelation mit hämodynamischen Parametern

  2002cites this paper
• Nitric Oxide Involvement in Septic Shock: Do Human Beings behave like Rodents?

  1996cites this paper
• Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre‐eclampsia

  1996cites this paper
• Effect of isosorbide‐5‐mononitrate on plasma and urine levels of cyclic GMP in relation to exercise in coronary patients compared with control subjects

  1995cites this paper
• [Organic nitrates. I. Mechanism of action and new therapeutic approaches in myocardial ischemia].

  1995cites this paper
• Failure of nitric oxide donors to alter arrhythmias induced by acute myocardial ischaemia or reperfusion in anaesthetized rats

  1995cites this paper
• Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level

  1994cites this paper